Open AccessImpacts of Generic Competition and Benefit Management Practices on Spending for Prescription Drugs: Evidence from Medicare’s Part D Benefit
Author(s) -
Steven H. Sheingold,
Nguyen Nguyen
Publication year - 2014
Publication title -
medicare and medicaid research review
Language(s) - English
Resource type - Journals
ISSN - 2159-0354
DOI - 10.5600/mmrr.004.01.a01
Subject(s) - copayment , medical prescription , competition (biology) , competitor analysis , medicare part d , prescription drug , business , cost sharing , generic drug , actuarial science , drug , medicine , marketing , economics , health care , pharmacology , health insurance , ecology , biology , economic growth , nursing
This study estimates the effects of generic competition, increased cost-sharing, and benefit practices on utilization and spending for prescription drugs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom